Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model
Min Wei, Kunwei Shen(Shanghai Jiao Tong University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Bingya Liu(Shanghai Jiao Tong University), Zhiwei Wang(Ruijin Hospital), Qing Zhang(National Medical Products Administration), Baosan Han(XinHua Hospital), Weiguo Chen(Hunan University of Traditional Chinese Medicine), Li Zhu(Jiangsu University), Jianrong He(Shanghai Jiao Tong University), Yafen Li(Ruijin Hospital), Zhongyin Yang(Shanghai Jiao Tong University), Qinlong Gu(Shanghai Jiao Tong University), Hongliang Yao(Central South University)
Cited by 21
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231